Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Male pattern baldness may predict prostate cancer risk.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Men with pattern baldness may have a higher risk of prostate issues.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Prostate cancer risk is not linked to blood testosterone levels.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Finasteride treats hair loss and reduces prostate cancer risk.

Higher serum androgens contribute to male pattern baldness.

No link found between hair loss severity and PSA levels in men.

No link between hair loss severity and PSA levels in men.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Gene variation affects prostate issues and hair loss.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Large prostate patients more likely to have hair loss.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.